Yuwei Wang, Ph.D.
Affiliations: | 2011 | Pharmaceutics and Pharmaceutical Chemistry | University of Utah, Salt Lake City, UT |
Area:
PharmacyGoogle:
"Yuwei Wang"Parents
Sign in to add mentorDavid W. Grainger | grad student | 2011 | University of Utah | |
(Local delivery of small interfering RNA to inhibit osteoporosis using a combination device strategy.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Wang Y, Grainger DW. (2019) Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments. Advanced Drug Delivery Reviews |
Wang Y, Liu J, Zhang J, et al. (2014) A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs. International Journal of Medical Sciences. 11: 479-87 |
Ying W, Liu J, Tsang KY, et al. (2014) Abstract 4578: A novel polymer-anticancer drug micelle formulation showing enhanced efficacy over Abraxane Cancer Research. 74: 4578-4578 |
Wang Y, Grainger DW. (2014) Barriers to advancing nanotechnology to better improve and translate nanomedicines Frontiers of Chemical Science and Engineering. 8: 265-275 |
Wang Y, Grainger DW. (2013) Developing siRNA therapies to address osteoporosis. Therapeutic Delivery. 4: 1239-46 |
Wang Y, Tran KK, Shen H, et al. (2012) Selective local delivery of RANK siRNA to bone phagocytes using bone augmentation biomaterials. Biomaterials. 33: 8540-7 |
Yang D, Liu X, Jiang X, et al. (2012) Effect of molecular weight of PGG-paclitaxel conjugates on in vitro and in vivo efficacy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 124-31 |
Wang Y, Grainger DW. (2012) RNA therapeutics targeting osteoclast-mediated excessive bone resorption. Advanced Drug Delivery Reviews. 64: 1341-57 |
Wang Y, Panasiuk A, Grainger DW. (2011) Small interfering RNA knocks down the molecular target of alendronate, farnesyl pyrophosphate synthase, in osteoclast and osteoblast cultures. Molecular Pharmaceutics. 8: 1016-24 |
Takahashi H, Wang Y, Grainger DW. (2010) Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 147: 400-7 |